Cell Culture Industry Overview

The global cell culture market size was estimated at USD 16.59 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.32% from 2023 to 2030.

Its growth can be attributed to the rapid adoption of cell culture techniques to develop substrates for the safe production of viral vaccines, and the rising global demand for advanced therapy medicinal products. Furthermore, novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development & vaccine production are expected to drive the market growth over the forecast period. The COVID-19 pandemic has presented researchers with the opportunity to investigate the novel contagious virus for the creation of therapeutic and diagnostic tools.

Gather more insights about the market drivers, restrains and growth of the Cell Culture Market

Numerous prominent pharmaceutical and biotechnology companies have been engaging in extensive R&D efforts to produce innovative vaccines, therapies, and testing kits. As a result, there has been a substantial increase in the need for cell culture tools in research applications. Furthermore, the pandemic has increased the demand for new cell-based models, organoids, and high-throughput screening platforms for research & drug discovery efforts. The urgency to combat the pandemic increased the demand for bioreactors and culture systems for applications in vaccine production and drug testing during the pandemic. In addition, several emerging and established players undertook various initiatives to capitalize on the increased demand for cell culture products due to the COVID-19 pandemic.

For instance, in January 2021, Captivate Bio, based in Massachusetts, U.S., launched its portfolio of cell culture tools for accelerating research applications for COVID-19 and other emerging diseases. Furthermore, in August 2022, Thermo Fisher Scientific expanded its New York-based dry powder media manufacturing facility to support the global demand for media products required for manufacturing COVID-19 vaccines and other biologics. Such initiatives are likely to positively impact the market growth over the forecast period. Furthermore, cell culture technology has applications in the development of functional tissues and organs as it enables researchers to create artificial organs that can replace damaged or malfunctioning organs in patients.

The potential impact of artificial organs in improving the quality of life for patients with organ failure is substantial and can drive the demand for cell culture techniques. In addition, cell culture-based vaccine production has gained prominence in recent years due to several advantages, including improved safety and faster production timelines offered by such vaccines. As a result, cell culture technology is being widely used for the production of several U.S.-licensed vaccines, including those for polio, rotavirus, smallpox, rubella, hepatitis, and chickenpox. Similarly, cell-based flu vaccines have been approved for use in several European countries. Hence, with the growing healthcare awareness and rising demand for vaccines, the market is anticipated to witness rapid expansion in the near future.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global recombinant DNA technology market size was valued at USD 728.9 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030.

• The global DNA diagnostics market size was estimated at USD 10.64 billion in 2023 and is projected to grow at a CAGR of 4.51% from 2024 to 2030.

Global Cell Culture Market Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the cell culture marketreport on the basis of product, application, and region:

Product Scope Outlook (Revenue, USD Million, 2018 - 2030)

·         Consumables

o    Sera

o    Fetal Bovine Serum

o    Other

o    Reagents

o    Albumin

o    Others

o    Media

o    Serum-free Media

o    CHO Media

o    HEK 293 Media

o    BHK Medium

o    Vero Medium

o    Other Serum-free Media

o    Classical Media

o    Stem Cell Culture Media

o    Chemically Defined Media

o    Specialty Media

o    Other Cell Culture Media

·         Instruments

o    Culture Systems

o    Incubators

o    Centrifuges

o    Cryostorage Equipment

o    Biosafety Equipment

o    Pipetting Instruments

Application Outlook (Revenue, USD Million, 2018 - 2030)

·         Biopharmaceutical Production

o    Monoclonal Antibodies

o    Vaccines Production

o    Other Therapeutic Proteins

·         Drug Development

·         Diagnostics

·         Tissue Culture & Engineering

·         Cell & Gene Therapy

·         Toxicity Testing

·         Other Applications

Regional Outlook (Revenue, USD Million, 2018 - 2030)

·         North America

o    US

o    Canada

·         Europe

o    Germany

o    UK

o    France

o    Italy

o    Spain

o    Denmark

o    Sweden

o    Norway

·         Asia Pacific

o    China

o    India

o    Japan

o    South Korea

o    Australia

o    Thailand

·         Latin America

o    Brazil

o    Mexico

o    Argentina

·         Middle East and Africa (MEA)

o    South Africa

o    Saudi Arabia

o    UAE

o    Kuwait

Key Companies & Market Share Insights

Key market players are undertaking strategic initiatives, such as mergers & acquisitions, expansions, and new product developments, to extend their product portfolio and strengthen their market presence. For instance, in July 2023, Merck invested around USD 25.85 million (€23 million), in Kansas, the U.S., to increase the production of cell culture media. Some of the prominent players in the global cell culture market include:

·         Sartorius AG

·         Danaher

·